Michael Schweizer, MD
Medical Oncology · Seattle, WANPI 1942463450
Payments from drug & device makers
Across 658 payments — averaging $41,711 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$8.8M
- Pfizer$8.1M
- Merck$5.4M
- Janssen Research & Development, LLC$3.7M
- Novartis$543K
- E.r. Squibb & Sons, L.L.C.$417K
- plus $521K from 8 others
Across 29 payments — averaging $775.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$22K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $8,776,897 |
| Pfizer | 199 | $8,149,607 |
| Merck | 31 | $5,375,463 |
| Janssen Research & Development, LLC | 123 | $3,662,509 |
| Novartis | 12 | $543,166 |
| E.r. Squibb & Sons, L.L.C. | 6 | $416,966 |
| Incyte Corporation | 236 | $183,549 |
| Eli Lilly | 7 | $138,332 |
| Bayer | 6 | $90,284 |
| Genentech, Inc. | 11 | $55,194 |
| Bristol Myers Squibb | 1 | $43,027 |
| Sanofi | 7 | $5,878 |
| Daiichi Sankyo Inc. | 2 | $4,050 |
| Janssen Scientific Affairs, LLC | 1 | $825 |
How this compares
$27,445,747 in reported general payments places this provider in the 95th percentile of 162 medical oncology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Seattle
- Ajay GopalSeattle$14.6M
- Scott TykodiSeattle$14.2M
- Evan YuSeattle$9.8M
- Christina BaikSeattle$9M
- David MaloneySeattle$8.5M
- Shailender BhatiaSeattle$7.5M
- Andrew CovelerSeattle$7.1M
- Jennifer SpechtSeattle$6.4M
- Vivian OehlerSeattle$5.5M
- Petros GrivasSeattle$5.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.